Jie Xia

4.0k total citations
147 papers, 2.9k citations indexed

About

Jie Xia is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Jie Xia has authored 147 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Molecular Biology, 30 papers in Oncology and 22 papers in Organic Chemistry. Recurrent topics in Jie Xia's work include Glycosylation and Glycoproteins Research (21 papers), Carbohydrate Chemistry and Synthesis (19 papers) and Cancer Cells and Metastasis (9 papers). Jie Xia is often cited by papers focused on Glycosylation and Glycoproteins Research (21 papers), Carbohydrate Chemistry and Synthesis (19 papers) and Cancer Cells and Metastasis (9 papers). Jie Xia collaborates with scholars based in China, United States and Canada. Jie Xia's co-authors include Khushi L. Matta, Robert D. Locke, Ni Tang, Kai Wang, Conrad F. Piskorz, James L. Alderfer, Daniel J. Moloney, Robert S. Haltiwanger, Ailong Huang and Li Liang and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Jie Xia

138 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jie Xia China 31 1.7k 425 411 372 367 147 2.9k
Kohichi Takada Japan 28 1.7k 1.0× 468 1.1× 148 0.4× 281 0.8× 330 0.9× 172 3.7k
Min Zhang China 32 1.5k 0.9× 579 1.4× 132 0.3× 476 1.3× 323 0.9× 209 4.1k
Bing Li China 32 2.2k 1.3× 1.0k 2.4× 219 0.5× 804 2.2× 356 1.0× 198 4.4k
Shuxia Wang China 33 1.9k 1.2× 490 1.2× 347 0.8× 603 1.6× 691 1.9× 154 4.7k
Fuqiang Wang China 31 1.4k 0.9× 543 1.3× 123 0.3× 267 0.7× 179 0.5× 147 2.9k
Jun Wu China 30 1.7k 1.0× 450 1.1× 90 0.2× 405 1.1× 566 1.5× 155 3.5k
Seiji Sato Japan 34 1.9k 1.1× 188 0.4× 343 0.8× 565 1.5× 396 1.1× 232 4.2k
Yuanfang Ma China 34 1.6k 0.9× 341 0.8× 117 0.3× 364 1.0× 783 2.1× 141 3.4k
Qing Xiao China 26 2.0k 1.2× 744 1.8× 109 0.3× 237 0.6× 316 0.9× 87 3.7k

Countries citing papers authored by Jie Xia

Since Specialization
Citations

This map shows the geographic impact of Jie Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jie Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jie Xia more than expected).

Fields of papers citing papers by Jie Xia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jie Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jie Xia. The network helps show where Jie Xia may publish in the future.

Co-authorship network of co-authors of Jie Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Jie Xia. A scholar is included among the top collaborators of Jie Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jie Xia. Jie Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cai, Weiwei, Fei Ge, Qing Zhou, et al.. (2025). Xin-Ji-Er-Kang balances mitochondrial fusion and fission to protect cardiomyocytes in mice with heart failure by regulating the ERα/SIRT3 pathway. Phytomedicine. 139. 156420–156420. 1 indexed citations
3.
Zhou, Qianqian, et al.. (2025). Analysis of status quo and influencing factors of personal mastery of patients after fracture surgery. Frontiers in Psychology. 16. 1635147–1635147.
4.
Xia, Jie, et al.. (2024). Compulsion is associated with impaired goal-directed and habitual learning and responding in obsessive-compulsive disorder. International Journal of Clinical and Health Psychology. 24(4). 100531–100531. 1 indexed citations
5.
Zhuang, Qian, Shan Wu, Shuang Shen, et al.. (2024). Association between sleep and gallstone disease in United States adults: A cross-sectional study. BMC Public Health. 24(1). 3291–3291. 2 indexed citations
6.
Shi, Yan, Caiyun Ma, Xin Ye, et al.. (2024). ETS translocation variant 5 (ETV5) promotes CD4+ T cell–mediated intestinal inflammation and fibrosis in inflammatory bowel diseases. Mucosal Immunology. 17(4). 584–598. 5 indexed citations
7.
Deng, Qiaodan, Cuicui Liu, Juchuanli Tu, et al.. (2024). SOSTDC1 Nuclear Translocation Facilitates BTIC Maintenance and CHD1‐Mediated HR Repair to Promote Tumor Progression and Olaparib Resistance in TNBC. Advanced Science. 11(29). e2306860–e2306860. 1 indexed citations
8.
Zhan, Ke, et al.. (2023). Topology Optimization for Minimum Compliance with Material Volume and Buckling Constraints under Design-Dependent Loads. Applied Sciences. 13(1). 646–646. 8 indexed citations
9.
Sha, Yu, et al.. (2023). RAD51 Inhibition Shows Antitumor Activity in Hepatocellular Carcinoma. International Journal of Molecular Sciences. 24(9). 7905–7905. 2 indexed citations
10.
Jiang, Rong, Jin Xiang, Peng Zhou, et al.. (2023). Identification of a diketopiperazine‐based O‐GlcNAc transferase inhibitor sensitizing hepatocellular carcinoma to CDK9 inhibition. FEBS Journal. 290(18). 4543–4561. 5 indexed citations
11.
12.
Sha, Yu, Liangjun Qiao, Dina Liu, et al.. (2023). PLEKHG5 is stabilized by HDAC2-related deacetylation and confers sorafenib resistance in hepatocellular carcinoma. Cell Death Discovery. 9(1). 176–176. 9 indexed citations
13.
Zhou, Peng, Wen‐Yi Chang, Luyi Huang, et al.. (2023). O-GlcNAcylation of SPOP promotes carcinogenesis in hepatocellular carcinoma. Oncogene. 42(10). 725–736. 17 indexed citations
14.
Wu, Xiaohong, Chang Chen, Kai Wang, et al.. (2023). SLC27A5 promotes sorafenib-induced ferroptosis in hepatocellular carcinoma by downregulating glutathione reductase. Cell Death and Disease. 14(1). 22–22. 58 indexed citations
15.
Xia, Jie, et al.. (2023). The impact of student engagement on satisfaction with medical education in china: a supplementary perspective. Advances in Health Sciences Education. 28(4). 1265–1288. 6 indexed citations
16.
Yang, Yang, Jie Hu, Xue-Fei Cai, et al.. (2022). Structure-Based Discovery of N-Sulfonylpiperidine-3-Carboxamides as Novel Capsid Assembly Modulators for Potent Inhibition of HBV Replication. Viruses. 14(2). 348–348. 7 indexed citations
17.
Chen, Yuxin, Yang Dai, Jie Xia, et al.. (2022). Serum Pharmacochemistry Combining Network Pharmacology to Discover the Active Constituents and Effect of Xijiao Dihuang Tang Prescription for Treatment of Blood‐Heat and Blood‐Stasis Syndrome‐Related Disease. Oxidative Medicine and Cellular Longevity. 2022(1). 6934812–6934812. 18 indexed citations
18.
Jin, Xiang, Chang Chen, Rui Liu, et al.. (2021). Gluconeogenic enzyme PCK1 deficiency promotes CHK2 O-GlcNAcylation and hepatocellular carcinoma growth upon glucose deprivation. Journal of Clinical Investigation. 131(8). 85 indexed citations
19.
Jin, Xiang, Yuhong Zhang, Lin Tuo, et al.. (2019). Transcriptomic changes associated with PCK1 overexpression in hepatocellular carcinoma cells detected by RNA-seq. Genes & Diseases. 7(1). 150–159. 8 indexed citations
20.
Xia, Jie, James L. Alderfer, Conrad F. Piskorz, & Khushi L. Matta. (2000). Total Synthesis of Sialylated and Sulfated Oligosaccharide Chains from Respiratory Mucins. Chemistry - A European Journal. 6(18). 3442–3451. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026